REPRESENTING THE RESULTS OF SUBGROUP ANALYSIS IN COMPARATIVE CLINICAL STUDIES BY A GRAPH

Assmann SF, Pocock SJ, Enos LE and Kasten LE (2000). Subgroup analysis and other

(mis)uses of baseline data in clinical trials. Lancet. 355(9209): 1064–1069.

Guillemin F (2007). Primer: the fallacy of subgroup analysis. Nature Clinical Practice

Rheumatology. 3: 407–413.

Harrington D, D’Agostino Sr RB, Gatsonis C, Hogan JW, Hunter DJ et al. (2019).

New guidelines for statistical reporting in the journal. New England Journal of

Medicine. 381(3): 285–286.

Moy´e LA and Deswal A (2001). Trials within trials: Confirmatory subgroup analyses

in controlled clinical experiments. Controlled Clinical Trials. 22(6): 605–619.

Priebe HJ (2020). Problems of subgroup analysis in randomized controlled trial. BMC

Anesthesiology. 20: 186.

Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM et al. (2012). Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

BMJ. 344: e1553.

Representing the results of subgroup analysis in comparative clinical studies by a graph

11

Thompson SG and Higgins JPT (2002). How should meta-regression analyses be undertaken and interpreted?. Statistics in Medicine. 21(11): 1559–1573.

White, IR and Elbourne, D. (2005). Assessing subgroup effects with binary data: can

the use of different effect measures lead to different conclusions?. BMC Medical

Research Methodology. 5: 15.

European Medicines Agency (Accessed: 2021–07–27). Guideline on the investigation

of subgroups in confirmatory clinical trials. https://www.ema.europa.eu/en/

investigation-subgroups-confirmatory -clinical-trials.

Fleming TR and Harrington DP. (2005).

John Wiley & Sons.

Counting Processes and Survival Analysis.

Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW et al. (2019).

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. New

England Journal of Medicine. 38: 2021–2031.

European Medicines Agency (Accessed: 2019–11–13). Opdivo : Epar - product information. https://www.ema.europa.eu/en/medicines/human/EPAR/opdivo,

Received: November 13, 2023

Revised: December 11, 2023

Accept: December 11, 2023

...